Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Auto-SCT for AML in second remission: CALGB study 9620.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Auto-SCT for AML in second remission: CALGB study 9620.
Auto-SCT for AML in second remission: CALGB study 9620. Bone Marrow Transplant. 2009 Sep; 44(6):353-9.
View in:
PubMed
subject areas
Adult
Aged
Aging
Antigens, CD34
Antimetabolites, Antineoplastic
Antineoplastic Agents, Phytogenic
Combined Modality Therapy
Cytarabine
Disease-Free Survival
Etoposide
Female
Humans
Ideal Body Weight
Infusions, Intravenous
Kaplan-Meier Estimate
Leukemia, Myeloid, Acute
Male
Middle Aged
Peripheral Blood Stem Cell Transplantation
Remission Induction
Transplantation, Autologous
Treatment Outcome
Treatment Refusal
Young Adult
authors with profiles
Richard A. Larson